Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 756

1.

Latin American chronic urticaria registry (CUR) contribution to the understanding and knowledge of the disease in the region.

Gómez RM, Jares E, Borges MS, Baiardini I, Canonica GW, Passalacqua G, Kaplan A, Latour P, Costa E, Dias G, Lavrut J; SLAAI CUR group.

World Allergy Organ J. 2019 Jun 13;12(6):100042. doi: 10.1016/j.waojou.2019.100042. eCollection 2019.

2.

Bronchodilator reversibility in asthma and COPD: Findings from three large population studies.

Janson C, Malinovschi A, Amaral AFS, Accordini S, Bousquet J, Sonia Buist A, Canonica GW, Dahlén B, Garcia-Aymerich J, Gnatiuc L, Kowalski ML, Patel J, Tan W, Torén K, Zuberbier T, Burney P, Jarvis D.

Eur Respir J. 2019 Jun 20. pii: 1900561. doi: 10.1183/13993003.00561-2019. [Epub ahead of print]

PMID:
31221806
3.

Minimal important difference of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).

Baiardini I, Fasola S, Maurer M, Weller K, Canonica GW, Braido F.

Allergy. 2019 Jun 6. doi: 10.1111/all.13939. [Epub ahead of print] No abstract available.

PMID:
31169906
4.

Treatable traits in chronic rhinosinusitis with nasal polyps.

Heffler E, Malvezzi L, Pirola F, Zięba N, Paoletti G, Mercante G, Spriano G, Canonica GW.

Curr Opin Allergy Clin Immunol. 2019 Aug;19(4):373-378. doi: 10.1097/ACI.0000000000000544.

PMID:
31135395
5.

EUFOREA consensus on biologics for CRSwNP with or without asthma.

Fokkens WJ, Lund V, Bachert C, Mullol J, Bjermer L, Bousquet J, Canonica GW, Deneyer L, Desrosiers M, Diamant Z, Han J, Heffler E, Hopkins C, Jankowski R, Joos G, Knill A, Lee J, Lee SE, Mariën G, Pugin B, Senior B, Seys SF, Hellings PW.

Allergy. 2019 May 15. doi: 10.1111/all.13875. [Epub ahead of print] Review.

PMID:
31090937
6.

When to stop biologicals. Severe asthma exacerbation after mepolizumab discontinuation

Bagnasco D, Aloè T, Sclifò F, Ferrantino MG, Marugo F, Arcadipane F, Manfredi A, Canonica GW, Passalacqua G.

Eur Ann Allergy Clin Immunol. 2019 May 15;51(3):135-137. doi: 10.23822/EurAnnACI.1764-1489.88. No abstract available.

7.

Responders and nonresponders to pharmacotherapy and allergen immunotherapy.

Jakalski M, Bozek A, Canonica GW.

Hum Vaccin Immunother. 2019 Jun 21:1-7. doi: 10.1080/21645515.2019.1614397. [Epub ahead of print]

PMID:
31070995
8.

2019 ARIA Care pathways for allergen immunotherapy.

Bousquet J, Pfaar O, Togias A, Schünemann HJ, Ansotegui I, Papadopoulos NG, Tsiligianni I, Agache I, Anto JM, Bachert C, Bedbrook A, Bergmann KC, Bosnic-Anticevich S, Bosse I, Brozek J, Calderon MA, Canonica GW, Caraballo L, Cardona V, Casale T, Cecchi L, Chu D, Costa E, Cruz AA, Czarlewski W, Durham SR, Du Toit G, Dykewicz M, Ebisawa M, Fauquert JL, Fernandez-Rivas M, Fokkens WJ, Fonseca J, Fontaine JF, Gerth van Wijk R, Haahtela T, Halken S, Hellings PW, Ierodiakonou D, Iinuma T, Ivancevich JC, Jacobsen L, Jutel M, Kaidashev I, Khaitov M, Kalayci O, Kleine Tebbe J, Klimek L, Kowalski ML, Kuna P, Kvedariene V, La Grutta S, Larenas-Linemann D, Lau S, Laune D, Le L, Lodrup Carlsen K, Lourenço O, Malling HJ, Marien G, Menditto E, Mercier G, Mullol J, Muraro A, O'Hehir R, Okamoto Y, Pajno GB, Park HS, Panzner P, Passalacqua G, Pham-Thi N, Roberts G, Pawankar R, Rolland C, Rosario N, Ryan D, Samolinski B, Sanchez-Borges M, Scadding G, Shamji MH, Sheikh A, Sturm GJ, Todo Bom A, Toppila-Salmi S, Valentin-Rostan M, Valiulis A, Valovirta E, Ventura MT, Wahn U, Walker S, Wallace D, Waserman S, Yorgancioglu A, Zuberbier T; ARIA Working Group.

Allergy. 2019 Apr 7. doi: 10.1111/all.13805. [Epub ahead of print]

PMID:
30955224
9.

Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry.

Canonica GW, Colombo GL, Bruno GM, Di Matteo S, Martinotti C, Blasi F, Bucca C, Crimi N, Paggiaro P, Pelaia G, Passalaqua G, Senna G, Heffler E; SANI Network.

World Allergy Organ J. 2019 Jan 26;12(1):100007. doi: 10.1016/j.waojou.2018.12.001. eCollection 2019.

10.

Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma.

Bousquet J, Bedbrook A, Czarlewski W, Onorato GL, Arnavielhe S, Laune D, Mathieu-Dupas E, Fonseca J, Costa E, Lourenço O, Morais-Almeida M, Todo-Bom A, Illario M, Menditto E, Canonica GW, Cecchi L, Monti R, Napoli L, Ventura MT, De Feo G, Fokkens WJ, Chavannes NH, Reitsma S, Cruz AA, da Silva J, Serpa FS, Larenas-Linnemann D, Fuentes Perez JM, Huerta-Villalobos YR, Rivero-Yeverino D, Rodriguez-Zagal E, Valiulis A, Dubakiene R, Emuzyte R, Kvedariene V, Annesi-Maesano I, Blain H, Bonniaud P, Bosse I, Dauvilliers Y, Devillier P, Fontaine JF, Pépin JL, Pham-Thi N, Portejoie F, Picard R, Roche N, Rolland C, Schmidt-Grendelmeier P, Kuna P, Samolinski B, Anto JM, Cardona V, Mullol J, Pinnock H, Ryan D, Sheikh A, Walker S, Williams S, Becker S, Klimek L, Pfaar O, Bergmann KC, Mösges R, Zuberbier T, Roller-Wirnsberger RE, Tomazic PV, Haahtela T, Salimäki J, Toppila-Salmi S, Valovirta E, Vasankari T, Gemicioğlu B, Yorgancioglu A, Papadopoulos NG, Prokopakis EP, Tsiligianni IG, Bosnic-Anticevich S, O'Hehir R, Ivancevich JC, Neffen H, Zernotti ME, Kull I, Melén E, Wickman M, Bachert C, Hellings PW, Brusselle G, Palkonen S, Bindslev-Jensen C, Eller E, Waserman S, Boulet LP, Bouchard J, Chu DK, Schünemann HJ, Sova M, De Vries G, van Eerd M, Agache I, Ansotegui IJ, Bewick M, Casale T, Dykewick M, Ebisawa M, Murray R, Naclerio R, Okamoto Y, Wallace DV; The MASK study group.

Clin Transl Allergy. 2019 Mar 11;9:16. doi: 10.1186/s13601-019-0252-0. eCollection 2019. Review.

11.

The cross-cultural validation of the English version of RhinAsthma patient's perspective (RAPP).

Lim MC, Baiardini I, Molinengo G, Navarro-Locsin CG, Canonica GW, Braido F.

J Asthma. 2019 Mar 25:1-7. doi: 10.1080/02770903.2019.1590595. [Epub ahead of print]

PMID:
30907184
12.

Clinical outcomes related to molecular allergy diagnosis.

Melioli G, Puggioni F, Racca F, Descalzi D, Canonica GW, Heffler E.

Curr Opin Allergy Clin Immunol. 2019 Jun;19(3):204-208. doi: 10.1097/ACI.0000000000000526.

PMID:
30844848
13.

Microarray Immunodiagnostics for Aeroallergens.

Heffler E, Puggioni F, Descalzi D, Racca F, Canonica GW, Melioli G.

Curr Allergy Asthma Rep. 2019 Feb 15;19(1):10. doi: 10.1007/s11882-019-0832-z. Review.

PMID:
30771109
14.

The Portuguese version of Rhinitis and Asthma Patient's Perspective (RAPP): Validation and assessment.

Todo-Bom A, Braido F, Molinengo G, Loureiro C, Canonica GW, Baiardini I.

Pulmonology. 2019 Feb 5. pii: S2531-0437(19)30005-4. doi: 10.1016/j.pulmoe.2018.10.009. [Epub ahead of print]

15.

New drugs in early-stage clinical trials for allergic rhinitis.

Heffler E, Brussino L, Del Giacco S, Paoletti G, Minciullo PL, Varricchi G, Scadding G, Malvezzi L, De Virgilio A, Spriano G, Puggioni F, Fornero M, Rolla G, Canonica GW.

Expert Opin Investig Drugs. 2019 Mar;28(3):267-273. doi: 10.1080/13543784.2019.1571581. Epub 2019 Jan 24. Review.

PMID:
30676119
16.

Personalized Approach to Severe Asthma.

Heffler E, Canonica GW, Diamant Z, Fonseca J, Malinovschi A.

Biomed Res Int. 2018 Dec 24;2018:2465172. doi: 10.1155/2018/2465172. eCollection 2018. No abstract available.

17.

Pharmacokinetics and pharmacodynamics of monoclonal antibodies for asthma treatment.

Bagnasco D, Heffler E, Testino E, Passalacqua G, Canonica GW.

Expert Opin Drug Metab Toxicol. 2019 Feb;15(2):113-120. doi: 10.1080/17425255.2019.1568409. Epub 2019 Jan 24. Review.

PMID:
30632416
18.

Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life.

Lombardi C, Bagnasco D, Caruso C, D'Amato M, Menzella F, Milanese M, Senna G, Canonica GW, Passalacqua G.

Pulm Pharmacol Ther. 2019 Feb;54:87-89. doi: 10.1016/j.pupt.2018.12.003. Epub 2018 Dec 29.

PMID:
30597278
19.

Cutting Edge: Biomarkers for Chronic Spontaneous Urticaria.

Folci M, Heffler E, Canonica GW, Furlan R, Brunetta E.

J Immunol Res. 2018 Nov 21;2018:5615109. doi: 10.1155/2018/5615109. eCollection 2018. Review.

20.

ARIA pharmacy 2018 "Allergic rhinitis care pathways for community pharmacy": AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project.

Bosnic-Anticevich S, Costa E, Menditto E, Lourenço O, Novellino E, Bialek S, Briedis V, Buonaiuto R, Chrystyn H, Cvetkovski B, Di Capua S, Kritikos V, Mair A, Orlando V, Paulino E, Salimäki J, Söderlund R, Tan R, Williams DM, Wroczynski P, Agache I, Ansotegui IJ, Anto JM, Bedbrook A, Bachert C, Bewick M, Bindslev-Jensen C, Brozek JL, Canonica GW, Cardona V, Carr W, Casale TB, Chavannes NH, Correia de Sousa J, Cruz AA, Czarlewski W, De Carlo G, Demoly P, Devillier P, Dykewicz MS, Gaga M, El-Gamal Y, Fonseca J, Fokkens WJ, Guzmán MA, Haahtela T, Hellings PW, Illario M, Ivancevich JC, Just J, Kaidashev I, Khaitov M, Khaltaev N, Keil T, Klimek L, Kowalski ML, Kuna P, Kvedariene V, Larenas-Linnemann DE, Laune D, Le LTT, Lodrup Carlsen KC, Mahboub B, Maier D, Malva J, Manning PJ, Morais-Almeida M, Mösges R, Mullol J, Münter L, Murray R, Naclerio R, Namazova-Baranova L, Nekam K, Nyembue TD, Okubo K, O'Hehir RE, Ohta K, Okamoto Y, Onorato GL, Palkonen S, Panzner P, Papadopoulos NG, Park HS, Pawankar R, Pfaar O, Phillips J, Plavec D, Popov TA, Potter PC, Prokopakis EP, Roller-Wirnsberger RE, Rottem M, Ryan D, Samolinski B, Sanchez-Borges M, Schunemann HJ, Sheikh A, Sisul JC, Somekh D, Stellato C, To T, Todo-Bom AM, Tomazic PV, Toppila-Salmi S, Valero A, Valiulis A, Valovirta E, Ventura MT, Wagenmann M, Wallace D, Waserman S, Wickman M, Yiallouros PK, Yorgancioglu A, Yusuf OM, Zar HJ, Zernotti ME, Zhang L, Zidarn M, Zuberbier T, Bousquet J.

Allergy. 2018 Dec 18. doi: 10.1111/all.13701. [Epub ahead of print] Review.

PMID:
30565275

Supplemental Content

Loading ...
Support Center